Failure in HiRes Ultra Series Recall Devices Does Not Necessarily Lead to Decrement in Performance.

Erin HarveyMuhammad KhokharMichael S HarrisJazzmyne AdamsDavid R Friedland

Published in: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2024)

Proactive monitoring using EFI identifies a higher rate of Ultra Series V1 device failure than previously reported. However, about 20% of these patients may not have subjective change in hearing or objective decline in test scores and could be observed. Should performance worsen, reimplantation provides significant improvement in speech recognition.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
genome wide
hearing loss
patient reported